HIVE Blockchain Applied sciences (NASDAQ: HIVE) shares are buying and selling decrease in sympathy with the worth of Bitcoin and Ethereum which dipped after the Individuals’s Financial institution of China stated all crypto-related actions are unlawful.
The corporate additionally reported FY21 earnings outcomes, which may be impacting value motion.
HIVE Blockchain Applied sciences reported FY21 EPS of $0.12, up from $(0.01) yr over yr and revenue from digital forex mining of $66.7 million, up 128% yr over yr.
HIVE Blockchain Applied sciences Ltd is within the enterprise of offering infrastructure options within the blockchain business. It focuses on the mining and sale of digital currencies.
Eventually test, the inventory was buying and selling 2.03% decrease at $2.9 per share. HIVE Blockchain Applied sciences has a 52-week excessive of $5.75 and a 52-week low of $0.23.
© 2021 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.